Estimations des analystes de Wall Street pour Cocrystal Pharma, Inc. (COCP): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-13 | $-0.15 | ||
| 2026-08-13 | $-0.23 | $-0.17 | -39.4% |
| 2026-05-15 | $-0.17 | $-0.15 | -13.3% |
| 2026-03-31 | $-0.17 | $-0.18 | +5.6% |
| 2025-11-14 | $-0.19 | $-0.22 | +13.6% |
| 2025-08-14 | $-0.20 | $-0.30 | +33.3% |
| 2025-05-15 | $-0.23 | $-0.52 | +55.8% |
| 2025-03-31 | $-0.32 | $-0.55 | +41.8% |
Ratios de valorisation
| Prix / Valeur comptable | 14.67 |
| EV / EBITDA | -1.55 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | 0 | 0 | 0 | $6.6M | $2.0M | 0 | 0 | 0 | 0 | 0 |
| Coût des Ventes | $201000 | $101000 | $50000 | $4.0M | $6.0M | $8.8M | $12.4M | $15.2M | $12.5M | $5.1M |
| Marge Brute | -$201000 | -$101000 | -$50000 | $2.6M | -$4.0M | -$8.8M | -$12.4M | -$15.2M | -$12.5M | -$5.1M |
| R&D | $101.7M | $5.8M | $58.6M | $4.0M | $6.0M | $8.8M | $12.4M | $15.2M | $12.5M | $5.1M |
| Frais Généraux | $4.1M | $2.4M | $4.4M | $4.9M | $5.6M | $5.4M | $5.7M | $6.0M | $5.3M | $4.0M |
| Charges Opérationnelles | $105.8M | $8.3M | $62.9M | $51.0M | $5.6M | $5.4M | $26.4M | $3.4M | $5.3M | $4.0M |
| Résultat Opérationnel | -$105.8M | -$8.3M | -$62.9M | -$48.4M | -$9.6M | -$14.2M | -$38.8M | -$18.6M | -$17.9M | -$9.0M |
| EBITDA | -$105.6M | -$7.4M | -$62.5M | -$2.2M | -$9.4M | -$14.0M | -$18.0M | -$21.0M | -$17.4M | -$8.5M |
| Charges d'Intérêt | 0 | 0 | 0 | $19000 | $8000 | $4000 | $2000 | 0 | 0 | 0 |
| Résultat Avant Impôts | -$104.3M | -$7.5M | -$62.6M | -$48.2M | -$9.6M | -$14.2M | -$38.8M | -$18.0M | -$17.5M | -$8.8M |
| Impôts | -$29.4M | -$6.9M | -$13.6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Résultat Net | -$74.9M | -$613000 | -$49.0M | -$48.2M | -$9.6M | -$14.2M | -$38.8M | -$18.0M | -$17.5M | -$8.8M |
| BPA | $-38.17 | $-0.30 | $-21.01 | $-15.78 | $-2.01 | $-1.85 | $-4.77 | $-0.00 | $-1.72 | $-0.78 |
| BPA Dilué | $-38.14 | $-0.30 | $-21.01 | $-15.78 | $-2.01 | $-1.85 | $-4.77 | $-0.00 | $-1.72 | $-0.78 |
| Actions en Circulation (Diluées) | $2.0M | $2.0M | $2.3M | $3.1M | $4.8M | $7.7M | $8.1M | $9.7M | $10.2M | $11.3M |
Prix
| Prix | $1.14 |
| Capitalisation | $16M |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: BOLT · BRTX · CING · DWTX · EVGN · IMNN · IMRN
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de COCP: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions